Thus, we can study how a single variant may down-regulate IGF1R signaling in a more precise pathway-specific manner to provide a protective environment to delay brain aging and prevent the development of neurological conditions such as Alzheimer’s disease (AD). The gene discussed is IGF1R; the disease is Alzheimer disease.